| Literature DB >> 24498367 |
Isadora S Lima1, Joselli S Silva1, Valter A Almeida1, Floriano G Leal Junior2, Patrício An Souza2, Daniela F Larangeira3, José P Moura-Neto4, Deborah B M Fraga5, Luiz A R de Freitas1, Washington L C dos-Santos1.
Abstract
In this work, we investigated the association between the disruption of splenic lymphoid tissue and the severity of visceral leishmaniasis in dogs. Clinical and laboratory data from 206 dogs were reviewed. Spleen sections collected during the euthanasia of these animals were analyzed, and the splenic lymphoid tissue samples were classified as well organized (spleen type 1), slightly disorganized (spleen type 2), or moderately to extensively disorganized (spleen type 3). Of 199 dogs with evidence of Leishmania infection, 54 (27%) had spleen type 1, 99 (50%) had spleen type 2, and 46 (23%) had spleen type 3. The number of clinical signs associated with visceral leishmaniasis was significantly higher in the animals with evidence of Leishmania infection and spleen type 2 or 3 than in the animals with spleen type 1. Alopecia, anemia, dehydration, dermatitis, lymphadenopathy, and onychogryphosis were all more frequent among animals with evidence of Leishmania infection and spleen type 3 than among the dogs with evidence of Leishmania infection and spleen type 1. The association between the severity of canine visceral leishmaniasis and the disorganization of the splenic lymphoid tissue was even more evident in the group of animals with positive spleen culture. Conjunctivitis and ulceration were also more common in the animals with spleen type 3 than in the animals with spleen type 1. The serum levels (median, interquartile range) of albumin (1.8, 1.4-2.3 g/dL) and creatinine (0.7, 0.4-0.8 mg/dL) were significantly lower and the serum levels of aspartate aminotransferase were significantly higher (57, 39-95 U) in animals with spleen type 3 than in animals with spleen type 1 (2.8, 2.4-3.4 g/dL; 0.9, 0.7-1.2 mg/dL and 23, 20-32 U, respectively). Our data confirm the hypothesis that disruption of the splenic lymphoid tissue is associated with a more severe clinical presentation of canine visceral leishmaniasis.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24498367 PMCID: PMC3911999 DOI: 10.1371/journal.pone.0087742
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
General characteristics of stray dogs collected between 2004 and 2010 from the streets of Jequié (Bahia State, Brazil), an area of endemic visceral leishmaniasis.
| PARAMETER | FREQUENCY | (%) |
| N | 206 | (100) |
| Gender: | ||
| Male | 116/206 | (56) |
| Female | 90/206 | (44) |
| Size: | ||
| Small | 45/204 | (22) |
| Medium | 122/204 | (60) |
| Large | 37/204 | (18) |
| Estimated age (years): | ||
| 0–2 | 28/154 | (18) |
| >2–5 | 102/154 | (66) |
| >6 | 24/154 | (16) |
| Clinical category: | ||
| Asymptomatic | 22/206 | (11) |
| Symptomatic | 184/206 | (89) |
| Splenic white pulp organization: | ||
| Type 1 | 57/206 | (28) |
| Type 2 | 101/206 | (49) |
| Type 3 | 48/206 | (23) |
Results of laboratory tests for Leishmania infection in dogs collected from the streets of an endemic area of visceral leishmaniasis in Brazil.
| LABORATORY | TEST AND RESULTS | NUMBER (%) | ||||
| CATEGORY | CULTURE | ELISA | LST | PCR | ||
|
|
|
| ||||
| P | P | P | P | 8 | (3.9) | |
| P | P | NT | P | 12 | (5.8) | |
| P | P | P | NT | 1 | (0.5) | |
| P | P | N | N | 3 | (1.5) | |
| P | P | N | NT | 3 | (1.5) | |
| P | P | NT | NT | 3 | (1.5) | |
| P | N | N | P | 2 | (1.0) | |
| P | P | N | P | 44 | (21.4) | |
| P | GZ | N | P | 1 | (0.5) | |
| P | N | NT | P | 2 | (1.0) | |
| P | GZ | NT | P | 1 | (0.5) | |
| P | GZ | NT | NT | 1 | (0.5) | |
| N | P | N | N | 11 | (5.3) | |
| N | P | N | ND | 1 | (0.5) | |
| N | P | NT | N | 2 | (1.0) | |
| N | P | P | N | 2 | (1.0) | |
| N | P | P | P | 3 | (1.5) | |
| N | P | N | P | 41 | (19.9) | |
| N | P | NT | P | 21 | (10.2) | |
| N | P | NT | NT | 6 | (2.9) | |
| N | N | P | P | 2 | (1.0) | |
| N | GZ | P | P | 1 | (0.5) | |
| N | N | N | P | 18 | (8.7) | |
| N | GZ | N | P | 1 | (0.5) | |
| N | N | NT | P | 6 | (2.9) | |
|
|
|
| ||||
| N | N | N | N | 4 | (1.9) | |
|
|
|
| ||||
| N | N | NT | N | 1 | (0.5) | |
| N | N | NT | NT | 2 | (1.0) | |
| TOTAL (%) | 206 | (100) | ||||
| Positive | 81/206(39) | 161/206(78) | 17/146(12) | 166/189(88) | 199/203 | (98) |
Culture of spleen aspirate;
leishmanin skin test;
PCR of spleen aspirate;
The denominator varies according with the number of animals subjected to the test. N = negative test; P = positive test; GZ = dubious test result; NT = not tested.
Distribution of clinical signs associated with visceral leishmaniasis in dogs with evidence of infection by L. infantum and type 1 (normal) or type 3 (moderately to severely disorganized) splenic white pulp.
| PARAMETER | SPLEEN TYPE 1 | SPLEEN TYPE 2 | SPLEEN TYPE 3 | TOTAL (%) | ||||
|
| 54 | (100) | 99 | (100) | 46 | (100) | 199 | (100) |
| Spleen type: | ||||||||
| Type 1 | 54 | (100) | 54 | (27) | ||||
| Type 2 | 99 | (100) | 99 | (50) | ||||
| Type 3 | 46 | (100) | 46 | (23) | ||||
| Clinical classification: | ||||||||
| Asymptomatic | 10/54 | (18) | 11/99 | (11) | 1/46 | (2) | 22/199 | (11) |
| Symptomatic | 44/54 | (82) | 88/99 | (89) | 45/46 | (98) | 177/199 | (89) |
| Clinical signs: | ||||||||
| Alopecia | 14/54 | (26) | 44/99 | (44) | 25/46 | (54) | 83/199 | (42) |
| Anemia | 10/33 | (30) | 31/70 | (44) | 22/36 | (61) | 63/139 | (45) |
| Conjunctivitis | 9/28 | (32) | 15/47 | (32) | 17/30 | (57) | 41/105 | (39) |
| Dehydration | 5/28 | (18) | 19/56 | (34) | 11/23 | (48) | 35/107 | (33) |
| Dermatitis | 6/26 | (23) | 24/43 | (56) | 13/23 | (56) | 43/92 | (47) |
| Emaciation | 19/54 | (35) | 43/99 | (43) | 24/46 | (52) | 86/199 | (43) |
| Erosion | 8/28 | (29) | 18/56 | (32) | 9/23 | (39) | 35/107 | (33) |
| Lymphadenopathy | 23/52 | (44) | 58/99 | (59) | 34/46 | (74) | 115/197 | (58) |
| Onychogryphosis | 7/54 | (13) | 29/97 | (30) | 16/45 | (36) | 52/196 | (27) |
| Pustule | 3/28 | (11) | 12/56 | (21) | 2/23 | (9) | 17/107 | (16) |
| Splenomegaly | 20/33 | (61) | 40/66 | (61) | 15/26 | (58) | 75/125 | (60) |
| Ulceration | 4/28 | (14) | 8/56 | (14) | 7/23 | (30) | 19/107 | (18) |
Chi-square test for trends:
P<0.05,
P<0.01,
P<0.005. The denominator varies according to the availability of the recorded data for each clinical sign.
Figure 1Clinical signs of visceral leishmaniasis and parasite burden in dogs naturally infected with Leishmania infantum and with different levels of disorganization of the splenic white pulp.
a) frequency of clinical signs associated with visceral leishmaniasis (alopecia, anemia, conjunctivitis, dermatitis, emaciation, lymphadenopathy, and onychogryphosis); b) parasite burden in the spleen, as estimated by qPCR (see details in the text). The spleen types include spleen type 1 (organized), type 2 (slightly disorganized), and type 3 (moderately to severely disorganized). The Kruskal-Wallis statistical test was used.
Figure 2Clinical signs of visceral leishmaniasis and parasite burden in dogs with active (positive spleen culture) or quiescent (negative spleen culture) infection by Leishmania infantum, with different levels of disorganization of the splenic white pulp.
a) frequency of clinical signs associated with visceral leishmaniasis (alopecia, anemia, conjunctivitis, dermatitis, emaciation, lymphadenopathy, and onychogryphosis); b) parasite burden in the spleen, as estimated by qPCR (see details in the text). The spleen types include spleen type 1 (organized) and type 3 (moderately to severely disorganized). The Kruskal-Wallis statistical test was used.
Distribution of clinical signs associated with visceral leishmaniasis in dogs with quiescent (negative spleen culture) or active (positive spleen culture) infection by L. infantum and type 1 (normal) or type 3 (moderately to severely disorganized) splenic white pulp (WP).
| NEGATIVE SPLEEN CULTURE | POSITIVE SPLEEN CULTURE | |||||||||||||
| CLINICAL SIGNS | WP TYPE 1 | WP TYPE 3 | WP TYPE 1 | WP TYPE 3 | ||||||||||
| N | (%) | N | (%) |
| [95% CI] | N | (%) |
| [95% CI] | N | (%) |
| [95% CI] | |
| Alopecia | 10/37 | (27) | 8/26 | (31) |
| [0.4–3.6] | 6/20 | (30) |
| [0.4–3.8] | 18/22 | (82) |
| [3.3–44.8] |
| Anemia | 9/23 | (39) | 10/19 | (53) |
| [0.5–5.9] | 2/12 | (17) |
| [0.0–1.7] | 14/19 | (74) |
| [1.2–16.3] |
| Conjunctivitis | 5/17 | (29) | 7/15 | (46) |
| [0.5–9.0] | 4/12 | (33) |
| [0.2–5.9] | 11/16 | (69) |
| [1.2–23.3] |
| Dehydration | 3/21 | (14) | 4/16 | (25) |
| [0.4–10.6] | 3/9 | (33) |
| [0.5–19.0] | 7/9 | (77) |
| [2.9–153.8] |
| Dermatitis | 3/16 | (19) | 5/10 | (50) |
| [0.7–25.3] | 4/11 | (36) |
| [0.4–14.4] | 8/13 | (62) |
| [1.3–37.2] |
| Emaciation | 8/37 | (22) | 8/26 | (31) |
| [0.5–5.0] | 12/20 | (60) |
| [1.6–17.9] | 16/22 | (73) |
| [2.8–32.8] |
| Erosion | 5/21 | (24) | 4/16 | (25) |
| [0.2–4.8] | 4/9 | (44) |
| [0.5–13.4] | 6/9 | (67) |
| [1.2–35.4] |
| Lymphadenopathy | 18/35 | (51) | 20/26 | (77) |
| [1.0–9.7] | 7/20 | (35) |
| [0.2–1.6] | 16/22 | (72) |
| [0.8–8.0] |
| Onychogryphosis | 6/37 | (16) | 4/25 | (16) |
| [0.2–3.9] | 2/20 | (10) |
| [0.1–3.2] | 12/22 | (54) |
| [1.8–20.8] |
| Pustule | 2/21 | (10) | 1/16 | (6) |
| [0.0–7.7] | 1/9 | (11) |
| [0.1–15.0] | 1/9 | (11) |
| [0.1–15.0] |
| Splenomegaly | 13/24 | (54) | 10/17 | (59) |
| [0.3–4.2] | 8/11 | (73) |
| [0.5–10.6] | 7/11 | (64) |
| [0.3–6.4] |
| Ulceration | 1/21 | (5) | 3/16 | (19) |
| [0.4–49.3] | 3/9 | (33) |
| [0.9–114.8] | 4/9 | (44) |
| [1.4–176.6] |
OR = odds ratio; CI = confidence interval;
P<0.05;
P<0.01;
P<0.005;
P<0.001 (Chi-square test or Fisher’s exact probability test).
Distribution of laboratory results in dogs with quiescent (negative spleen culture) or active (positive spleen culture) infection by L. infantum and type 1 (normal) or type 3 (moderately to severely disorganized) splenic white pulp (WP).
| CLINICAL | WITH NEGATIVE SPLEEN CULTURE | WITH POSITIVE SPLEEN CULTURE | ||||||
| PARAMETER | SPLEEN TYPE 1 | SPLEEN TYPE 3 | SPLEEN TYPE 1 | SPLEEN TYPE 3 | ||||
| MEDIAN | [p25–p75; | MEDIAN | [p25–p75; | MEDIAN | [p25–p75; | MEDIAN | [p25–p75; | |
| Albumin | 2.8 | [2.4–3.4; | 2.6 | [2.5–3.2; | 2.7 | [2.2–4.0; | 1.8 | [1.4–2.3; |
| Globulin | 4.8 | [3.9–7.2; | 7.0 | [5.2–9.7; | 4.6 | [4.0–6.6; | 5.7 | [4.0–6.5; |
| ALT | 23 |
| 36 | [29–46; | 26 |
| 57 | [38–95; |
| AST | 34 | [30–41; | 37 | [25–50; | 32 |
| 40 | [34–63; |
| Urea | 30 | [22–42; | 30 | [25–44; | 46 | [30–54; | 41 | [22–45; |
| Creatinine | 0.9 | [0.7–1.2; | 0.8 | [0.7–0.9; | 1.0 | [0.8–1.1; | 0.7 | [0.4–0.8; |
| Cholesterol | 162 | [142–183; | 180 | [161–203; | 180 | [142–218; | 238 | [136–358; |
| Triglycerides | 42 | [31–74; | 55 | [43–98; | 76 | [68–85; | 41 | [40–72; |
| C-reactive protein | 28 | [9–54; | ND | 32 | [17–40; | 44 | [39–48; | |
| Hematocrit | 38 | [27–43; | 31 |
| 42 | 19 |
| |
| Hemoglobin | 13 |
| 11 |
| 14 | 7 |
| |
| WBC count | 14 |
| 14 |
| 18 | 28 | [15–46; | |
| Neutrophils | 60 | [42–74; | 68 | [49–78; | 36 | 82 | [80–83; | |
| Monocytes | 5 |
| 2 |
| 8 |
| 4 |
|
| Lymphocytes | 16 |
| 43 | [14–77; | 22 |
| 8 |
|
| Eosinophils | 4 |
| 1 | [0–4; | 12 |
| 2 |
|
| Platelets | 130 | [57–168; | 161 | [96–232; | 161 | 155 | [80–375; | |
p25–p75 = interquartile range; ALT = alanine aminotransferase; AST = aspartate aminotransferase;
P<0.05,
P<0.01,
P<0.001 (Kruskal-Wallis test): animal groups with significant differences in the laboratory test are identified by the same character (a, b, b’, or c).